1 Jin, K. et al. Multimodal deep learning with feature level fusion for identification of choroidal neovascularization activity in age-related macular degeneration. Acta Ophthalmol100, e512-e520 (2022).
2 Shi, X. et al. Presence or absence of choroidal hyper-transmission by SD-OCT imaging distinguishes inflammatory from neovascular lesions in myopic eyes. Graefes Arch Clin Exp Ophthalmol258, 751-758 (2020).
3 Richey, B. F. et al. SMOKING, RURAL RESIDENCE AND DIABETES AS RISK FACTORS FOR PRESUMED OCULAR HISTOPLASMOSIS SYNDROME. Retina42, 369-374 (2022).
4 Ehrenberg, M. & Benny, O. Evolving multidimensional pharmacological approaches to CNV therapy in AMD. Current Eye Research, 1 (2017).
5 Mi, L., Chen, L., Liu, B., Wen, F. & Zhang, X. Long-Term Natural Outcomes of Simple Hemorrhage Associated with Lacquer Crack in High Myopia: A Risk Factor for Myopic CNV? Journal of ophthalmology2018, 1-7 (2018).
6 Budzinskaya, M. V. & Plyukhova, A. A. [Differential diagnosis of various types of fluids on the eye fundus in patients with age-related mac ular degeneration]. Vestn Oftalmol136, 354-358 (2020).
7 Khurana, R. N., Hill, L., Ghanekar, A. & Gune, S. Agreement of Spectral-Domain OCT with Fluorescein Leakage in Neovascular Age-Related Macular Degenera tion: Post Hoc Analysis of the HARBOR Study. Ophthalmol Retina (2020).
8 Chakravarthy, U. et al. Progression from Early/Intermediate to Advanced Forms of Age-Related Macular Degeneration in a Large UK Cohort: Rates and Risk Factors. Ophthalmol Retina4, 662-672 (2020).
9 Archer, D. B. & Gardiner, T. A. Morphologic fluorescein angiographic, and light microscopic features of experimental choroidal neovascularization. American journal of ophthalmology91, 297-311 (1981).
10 Cui, J., Liu, Y., Zhang, J. & Yan, H. An experimental study on choroidal neovascularization induced by Krypton laser in rat model. Photomedicine & Laser Surgery32, 30 (2014).
11 Dobi, E. T., Puliafito, C. A. & Destro, M. A new model of experimental choroidal neovascularization in the rat. Arch Ophthalmol107, 264-269 (1989).
12 Tobe, T. et al. Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol153, 1641-1646 (1998).
13 Grossniklaus, H. E., Kang, S. J. & Berglin, L. Animal models of choroidal and retinal neovascularization. Prog Retin Eye Res29, 500-519 (2010).
14 Yao, Y. G. Creating animal models, why not use the Chinese tree shrew (Tupaia belangeri chinensis)? Zool Res38, 118-126 (2017).
15 Xiao, J., Liu, R. & Chen, C. S. Tree shrew (Tupaia belangeri) as a novel laboratory disease animal model. Zool Res38, 127-137 (2017).
16 Levy, A. M., Fazio, M. A. & Grytz, R. Experimental myopia increases and scleral crosslinking using genipin inhibits cyclic softening in the tree shrew sclera. Ophthalmic Physiol Opt38, 246-256 (2018).
17 Guo, L., Frost, M. R., Siegwart, J. T. & Norton, T. T. Gene expression signatures in tree shrew sclera during recovery from minus-lens wear and during plus- lens wear. Mol Vis25, 311-328 (2019).
18 Lambert, V. et al. Matrix metalloproteinase-9 contributes to choroidal neovascularization. Am J Pathol161, 1247-1253 (2002).
19 Montezuma, S. R., Vavvas, D. & Miller, J. W. Review of the ocular angiogenesis animal models. Semin Ophthalmol24, 52-61 (2009).
20 Spilsbury, K., Garrett, K. L., Shen, W. Y., Constable, I. J. & Rakoczy, P. E. Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads t o the development of choroidal neovascularization. Am J Pathol157, 135-144 (2000).
21 Zahn, G. et al. Preclinical evaluation of the novel small-molecule integrin alpha5beta1 inhibitor JSM6427 in monkey a nd rabbit models of choroidal neovascularization. Arch Ophthalmol127, 1329-1335 (2009).
22 Qiu, G. et al. A new model of experimental subretinal neovascularization in the rabbit. Exp Eye Res83, 141-152 (2006).
23 Li, Y. et al. Real-time OCT guidance and multimodal imaging monitoring of subretinal injection induced choroidal ne ovascularization in rabbit eyes. Exp Eye Res186, 107714 (2019).
24 Lima, L. H., Farah, M. E., Gum, G., Ko, P. & de Carvalho, R. A. P. Sustained and targeted episcleral delivery of celecoxib in a rabbit model of retinal and choroidal ne ovascularization. Int J Retina Vitreous4, 31 (2018).
25 Liu, S. et al. A new rat model of treatment-naive quiescent choroidal neovascularization induced by human VEGF165 ov erexpression. Biol Open9 (2020).
26 Kokki, E., Karttunen, T., Olsson, V., Kinnunen, K. & Yl?-Herttuala, S. Human Vascular Endothelial Growth Factor A165 Expression Induces the Mouse Model of Neovascular Age-R elated Macular Degeneration. Genes (Basel)9 (2018).
27 Cao, J. et al. A subretinal matrigel rat choroidal neovascularization (CNV) model and inhibition of CNV and associat ed inflammation and fibrosis by VEGF trap. Invest Ophthalmol Vis Sci51, 6009-6017 (2010).
28 Haines, J. L. et al. Functional candidate genes in age-related macular degeneration: significant association with VEGF, VL DLR, and LRP6. Invest Ophthalmol Vis Sci47, 329-335 (2006).
29 Hu, W. et al. Expression of VLDLR in the retina and evolution of subretinal neovascularization in the knockout mous e model's retinal angiomatous proliferation. Invest Ophthalmol Vis Sci49, 407-415 (2008).
30 Heckenlively, J. R. et al. Mouse model of subretinal neovascularization with choroidal anastomosis. Retina23, 518-522 (2003).
31 Krzystolik, M. G. et al. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial g rowth factor antibody fragment. Arch Ophthalmol120, 338-346 (2002).
32 Ji, W. W. et al. Recombinant humanized anti-vascular endothelial growth factor monoclonal antibody efficiently suppres ses laser-induced choroidal neovascularization in rhesus monkeys. Eur J Pharm Sci109, 624-630 (2017).
33 elDirini, A. A., Ogden, T. E. & Ryan, S. J. Subretinal endophotocoagulation. A new model of subretinal neovascularization in the rabbit. Retina11, 244-249 (1991).
34 Kiilgaard, J. F. et al. A new animal model of choroidal neovascularization. Acta Ophthalmol Scand83, 697-704 (2005).
35 Gong, Y. et al. Optimization of an Image-Guided Laser-Induced Choroidal Neovascularization Model in Mice. PLoS One10, e0132643 (2015).
36 Ishikawa, K., Kannan, R. & Hinton, D. R. Molecular mechanisms of subretinal fibrosis in age-related macular degeneration. Exp Eye Res142, 19-25 (2016).
37 Cui, J., Liu, Y., Zhang, J. & Yan, H. An experimental study on choroidal neovascularization induced by Krypton laser in rat model. Photomed Laser Surg32, 30-36 (2014).
38 Lin, X., Wang, Q. & He, M. Repeated retinal photocoagulation in monkeys for the optimization of a laser-induced choroidal neovas cularization model. Exp Eye Res184, 1-7 (2019).
39 Inagaki, S. et al. Anti-vascular endothelial growth factor antibody limits vascular leakage and decreases subretinal fib rosis in a cynomolgus monkey choroidal neovascularization model. Curr Neurovasc Res (2020).
40 Shen, W. Y. et al. Predilection of the macular region to high incidence of choroidal neovascularization after intense la ser photocoagulation in the monkey. Arch Ophthalmol122, 353-360 (2004).
41 Shen, W. Y., Yu, M. J., Barry, C. J., Constable, I. J. & Rakoczy, P. E. Expression of cell adhesion molecules and vascular endothelial growth factor in experimental choroida l neovascularisation in the rat. Br J Ophthalmol82, 1063-1071 (1998).
42 Fan, Y. et al. Genome of the Chinese tree shrew. Nat Commun4, 1426 (2013).
43 Fan, Y. et al. Chromosomal level assembly and population sequencing of the Chinese tree shrew genome. Zool Res40, 506-521 (2019).
44 Ye, M. S. et al. Comprehensive annotation of the Chinese tree shrew genome by large-scale RNA sequencing and long-read isoform sequencing. Zool Res42, 692-709 (2021).
45 Hunt, D. M. et al. Molecular evolution of trichromacy in primates. Vision Res38, 3299-3306 (1998).
46 Jacobs, G. H. & Neitz, J. Spectral mechanisms and color vision in the tree shrew (Tupaia belangeri). Vision Res26, 291-298 (1986).
47 Samorajski, T., Ordy, J. M. & Keefe, J. R. Structural organization of the retina in the tree shrew (Tupaia glis). J Cell Biol28, 489-504 (1966).
48 Olvera-Monta?o, O. et al. Comparing The Efficacy Of An Anti-Human VEGF-A Neutralizing Antibody Versus Bevacizumab On A Laser-In duced Choroidal Neovascularization (CNV) Rhesus Monkey Model. Drug Des Devel Ther13, 3813-3821 (2019).
49 Ragauskas, S., Kielczewski, E., Vance, J., Kaja, S. & Kalesnykas, G. In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model. J Vis Exp (2018).
50 Book, B. et al. [Visual acuity in anti-VEGF therapy for AMD : Can specific characteristics in the SD-OCT help?]. Ophthalmologe114, 49-56 (2017).
51 Liu, Y., You, C., Zhang, Z., Zhang, J. & Yan, H. Roles of Treg/Th17 Cell Imbalance and Neuronal Damage in the Visual Dysfunction Observed in Experimen tal Autoimmune Optic Neuritis Chronologically. Neuromolecular Med17, 391-403 (2015).
52 Wang, R. S. et al. Establishing an experimental model of photodynamically induced anterior ischemic optic neuropathy. Vis Neurosci28, 155-162 (2011).
53 Eter, N. et al. In vivo visualization of dendritic cells, macrophages, and microglial cells responding to laser-induced damage in the fundus of the eye. Investigative Ophthalmology & Visual Science49, 3649 (2008).
54 Sakurai, E., Anand, A., Ambati, B. K., Van, R. N. & Ambati, J. Macrophage depletion inhibits experimental choroidal neovascularization. Investigative Ophthalmology & Visual Science44, 3578-3585 (2003).
55 Combadière, C. et al. CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. Journal of Clinical Investigation117, 2920 (2007).
56 Ferrara, N., Gerber, H. P. & Lecouter, J. The biology of VEGF and its receptors. Nature medicine9, 669-676 (2003).
57 Mammadzada, P., Gudmundsson, J., Kvanta, A. & André, H. Differential hypoxic response of human choroidal and retinal endothelial cells proposes tissue heterogeneity of ocular angiogenesis. Acta ophthalmologica94, 805-814 (2016).
58 Robinson, C. J. & Stringer, S. E. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. Journal of Cell Science114, 853 (2001).
59 Puri, M. C., Rossant, J., Alitalo, K., Bernstein, A. & Partanen, J. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. Embo j14, 5884-5891 (1995).
60 Asahara, T. et al. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascular ization. Circ Res83, 233-240 (1998).
61 Augustin, H. G., Koh, G. Y., Thurston, G. & Alitalo, K. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol10, 165-177 (2009).
62 Xu, J. et al. Over-expression of BMP4 inhibits experimental choroidal neovascularization by modulating VEGF and MMP -9. Angiogenesis15, 213-227 (2012).
63 Lambert, V. et al. MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. Faseb j17, 2290-2292 (2003).
64 Abdel-Rahman, M. H. et al. Investigation of the potential utility of a linomide analogue for treatment of choroidal neovascularization. Experimental eye research91, 837-843 (2010).
65 Hu, W. et al. Differences in the temporal expression of regulatory growth factors during choroidal neovascular development. Experimental eye research88, 79 (2009).
66 Jakobsson, L. & Meeteren, L. A. V. Transforming growth factor β family members in regulation of vascular function: In the light of vascular conditional knockouts. Experimental Cell Research319, 1264-1270 (2013).
67 Schlecht, A. et al. Deletion of Endothelial TGF-β Signaling Leads to Choroidal Neovascularization. American Journal of Pathology (2017).
68 Tong, J. P. & Yao, Y. F. Contribution of VEGF and PEDF to choroidal angiogenesis: a need for balanced expressions. Clinical Biochemistry39, 267-276 (2006).
69 Sarojini, H. et al. PEDF from mouse mesenchymal stem cell secretome attracts fibroblasts. Journal of Cellular Biochemistry104, 1793 (2008).
70 Yu, Y. J. et al. Inhibition of choroidal neovascularization by lentivirus-mediated PEDF gene transfer in rats. International Journal of Ophthalmology9, 1112-1120 (2016).